CL2011000146A1 - Uso de bacterias probióticas para aumentar la secreción de inmunoglobulina a (iga) en un infante. - Google Patents

Uso de bacterias probióticas para aumentar la secreción de inmunoglobulina a (iga) en un infante.

Info

Publication number
CL2011000146A1
CL2011000146A1 CL2011000146A CL2011000146A CL2011000146A1 CL 2011000146 A1 CL2011000146 A1 CL 2011000146A1 CL 2011000146 A CL2011000146 A CL 2011000146A CL 2011000146 A CL2011000146 A CL 2011000146A CL 2011000146 A1 CL2011000146 A1 CL 2011000146A1
Authority
CL
Chile
Prior art keywords
iga
infant
immunoglobulin
secretion
increase
Prior art date
Application number
CL2011000146A
Other languages
English (en)
Inventor
Florence Fichot Marie-Claire Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39769543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000146(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2011000146A1 publication Critical patent/CL2011000146A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Uso de bacterias probióticas para aumentar la secreción de inmunoglobulina a (IGA) en un infante.
CL2011000146A 2008-07-21 2011-01-21 Uso de bacterias probióticas para aumentar la secreción de inmunoglobulina a (iga) en un infante. CL2011000146A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08160806A EP2147678A1 (en) 2008-07-21 2008-07-21 Probiotics to increase IgA secretion in infants born by caesarean section

Publications (1)

Publication Number Publication Date
CL2011000146A1 true CL2011000146A1 (es) 2011-06-17

Family

ID=39769543

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000146A CL2011000146A1 (es) 2008-07-21 2011-01-21 Uso de bacterias probióticas para aumentar la secreción de inmunoglobulina a (iga) en un infante.

Country Status (15)

Country Link
US (1) US9060540B2 (es)
EP (2) EP2147678A1 (es)
CN (1) CN102159226B (es)
AU (1) AU2009273331B2 (es)
BR (1) BRPI0916275A2 (es)
CA (1) CA2731541A1 (es)
CL (1) CL2011000146A1 (es)
ES (1) ES2442344T3 (es)
MX (1) MX2011000737A (es)
MY (1) MY159072A (es)
PL (1) PL2315595T3 (es)
PT (1) PT2315595E (es)
RU (1) RU2496505C2 (es)
WO (1) WO2010010021A1 (es)
ZA (1) ZA201101336B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012009315A2 (en) * 2010-07-12 2012-01-19 The Regents Of The University Of California Bovine milk oligosaccharides
EP3366143A1 (en) 2011-06-20 2018-08-29 H.J. Heinz Company Brands LLC Probiotic compositions and methods
EP2609814A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
EP2811845B1 (en) * 2012-02-10 2015-12-09 N.V. Nutricia Maternal supplement to enhance immune system of an infant
DK2994150T3 (da) 2013-05-10 2019-06-11 Heinz Co Brands H J Llc Probiotika og fremgangsmåde til anvendelse
CN105899089A (zh) * 2013-12-19 2016-08-24 雀巢产品技术援助有限公司 用于减少婴儿代谢应激、降低肠道通透性和接近母乳喂养婴儿的生长速度的营养组合物
US9980950B2 (en) 2014-01-10 2018-05-29 Nestec S.A. Maternal vitamin B6 administration for the prevention of increased adiposity, overweight or obesity in the offspring
US10517891B2 (en) 2014-01-10 2019-12-31 Societe Des Produits Nestle S.A. Maternal vitamin B12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers
RU2016141131A (ru) * 2014-03-21 2018-04-23 Нестек С.А. Введение витамина b2 матери для профилактики повышенной тучности, избыточного веса или ожирения у потомства
MX2016015153A (es) * 2014-05-20 2017-03-07 Biogaia Ab Complementacion de microbioma neonatal.
CN104206539A (zh) * 2014-08-14 2014-12-17 澳优乳业（中国）有限公司 一种益生菌婴幼儿奶粉
RU2723687C2 (ru) * 2014-10-29 2020-06-17 Биогаиа Аб Применение l. reuteri для восстановления после дисбиоза микробиоты на ранних этапах развития
WO2016183535A1 (en) * 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
EP3331383B1 (en) 2015-08-04 2021-05-05 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
BR112018013501B1 (pt) * 2015-12-29 2022-12-20 N.V. Nutricia Uso de um ingrediente fermentado e oligossacarídeo não digerível
CN108697141A (zh) * 2015-12-29 2018-10-23 N·V·努特里奇亚 含有不可消化寡糖和非复制型产乳酸细菌的营养配方物
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
MX2019000881A (es) 2016-07-28 2019-07-01 Fonterra Cooperative Group Ltd Producto lacteo y proceso.
EP3618843A1 (en) * 2017-05-05 2020-03-11 Société des Produits Nestlé S.A. Treatment of infant colic
EP3812452A4 (en) * 2018-09-30 2021-11-03 Inner Mongolia Yili Industrial Group Co., Ltd. BIFIDOBACTERIUM LACTIS BL-99 AND ITS USES
CN114540247B (zh) * 2022-03-17 2023-11-28 江南大学 一株可提高肠道IgA水平并缓解肠炎的发酵乳杆菌CCFM1226及其应用
CN114517171B (zh) * 2022-03-17 2023-11-28 江南大学 一株可促进肠道分泌IgA的发酵乳杆菌CCFM1225及其应用
CN114540245B (zh) * 2022-03-17 2023-11-28 江南大学 一株同时具有缓解抑郁情绪及促进肠道分泌IgA功能的鼠李糖乳杆菌CCFM1228及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
EP0577904B1 (fr) 1992-07-06 1997-05-14 Societe Des Produits Nestle S.A. Bactérie lactique
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
PL1638414T3 (pl) * 2003-06-23 2009-12-31 Nestec Sa Mleko modyfikowane niemowlęce lub następne
JP5001830B2 (ja) * 2005-02-02 2012-08-15 株式会社明治 免疫賦活用組成物
BRPI0608782A2 (pt) * 2005-04-13 2010-01-26 Nestec Sa fórmula para bebê com probióticos
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
BRPI0708689A2 (pt) 2006-03-07 2011-06-07 Nestec Sa mistura simbiótica
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota

Also Published As

Publication number Publication date
CA2731541A1 (en) 2010-01-28
MY159072A (en) 2016-12-15
EP2147678A1 (en) 2010-01-27
EP2315595B1 (en) 2013-11-06
RU2011106319A (ru) 2012-08-27
AU2009273331A1 (en) 2010-01-28
EP2315595A1 (en) 2011-05-04
MX2011000737A (es) 2011-02-24
PT2315595E (pt) 2013-11-25
CN102159226A (zh) 2011-08-17
US9060540B2 (en) 2015-06-23
CN102159226B (zh) 2014-02-26
US20110129452A1 (en) 2011-06-02
BRPI0916275A2 (pt) 2015-11-10
ZA201101336B (en) 2012-07-25
RU2496505C2 (ru) 2013-10-27
AU2009273331B2 (en) 2014-12-04
ES2442344T3 (es) 2014-02-11
WO2010010021A1 (en) 2010-01-28
PL2315595T3 (pl) 2014-04-30

Similar Documents

Publication Publication Date Title
CL2011000146A1 (es) Uso de bacterias probióticas para aumentar la secreción de inmunoglobulina a (iga) en un infante.
SMT201600218B (it) Batterio per uso come probiotico per applicazioni nutrizionali e mediche
CL2012003385A1 (es) Tratamiento para la incontinencia.
BRPI1010574A2 (pt) cereal infantil compreendendo micro-organismos probióticos não replicantes.
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
CO6650338A2 (es) Antígenos de tuberculosis modificados
CL2012001050A1 (es) Composicion nutricional parea lactantes y/o ninos que comprende lactoferrina y probioticos; metodo para preparar dicha composicion; kit.
MX2009009079A (es) Anticuerpos anti-il-23p19 de ingenieria.
MX2009009080A (es) Anticuerpos anti-interleucina-23p19 manipulados por ingenieria genetica.
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
CL2013000238A1 (es) Uso de inhibores de la succinato deshidrogenasa y/o inhibidores del complejo iii para mejorar la relacion entre microorganismos dañinos y beneficiosos.
ECSP13012786A (es) Anticuerpos anti-pcsk9 y métodos de uso
BR112013023600A2 (pt) bactérias probióticas tendo atividade antioxidante e uso das mesmas
IN2012DN01920A (es)
SG195306A1 (en) Purification of biological products by constrained cohydration chromatography
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
BR112012015597A2 (pt) peptídeos de somatotropina suínos modificados e seus usos
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
MX357675B (es) Anticuerpos anti-jagged y métodos de uso.
WO2011034501A3 (en) Bandgap voltage reference with dynamic element matching
AR075840A1 (es) Expresion aumentada de genes de transhidrogenasa y su utilizacion en la produccion de etanol.
DK2414365T3 (da) SUBSTITUEREDE [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINER OG ANVENDELSE HERAF SOM KALIUMKANALMODULATORER
BR112012011463A2 (pt) uso de populações imunorregulatórias de célula nk para prognosticar a eficácia de anticorpos anti-il-2r em pacientes com esclerose múltipla.
EA201390670A1 (ru) Новый адъювант